Literature DB >> 22388039

NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4.

Jun Cui1, Yinyin Li, Liang Zhu, Dan Liu, Zhou Songyang, Helen Y Wang, Rong-Fu Wang.   

Abstract

Stringent control of the type I interferon signaling pathway is important for maintaining host immune responses and homeostasis, yet the molecular mechanisms responsible for its tight regulation are still poorly understood. Here we report that the pattern-recognition receptor NLRP4 regulated the activation of type I interferon mediated by double-stranded RNA or DNA by targeting the kinase TBK1 for degradation. NLRP4 recruited the E3 ubiquitin ligase DTX4 to TBK1 for Lys48 (K48)-linked polyubiquitination at Lys670, which led to degradation of TBK1. Knockdown of either DTX4 or NLRP4 abrogated K48-linked ubiquitination and degradation of TBK1 and enhanced the phosphorylation of TBK1 and the transcription factor IRF3. Our results identify a previously unrecognized role for NLRP4 in the regulation of type I interferon signaling and provide molecular insight into the mechanisms by which NLRP4-DTX4 targets TBK1 for degradation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22388039      PMCID: PMC3760161          DOI: 10.1038/ni.2239

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  32 in total

Review 1.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  NLRC5 limits the activation of inflammatory pathways.

Authors:  Szilvia Benko; Joao G Magalhaes; Dana J Philpott; Stephen E Girardin
Journal:  J Immunol       Date:  2010-07-07       Impact factor: 5.422

4.  IFI16 is an innate immune sensor for intracellular DNA.

Authors:  Leonie Unterholzner; Sinead E Keating; Marcin Baran; Kristy A Horan; Søren B Jensen; Shruti Sharma; Cherilyn M Sirois; Tengchuan Jin; Eicke Latz; T Sam Xiao; Katherine A Fitzgerald; Søren R Paludan; Andrew G Bowie
Journal:  Nat Immunol       Date:  2010-10-03       Impact factor: 25.606

5.  PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4.

Authors:  Fuping You; Hui Sun; Xiang Zhou; Wenxiang Sun; Shimin Liang; Zhonghe Zhai; Zhengfan Jiang
Journal:  Nat Immunol       Date:  2009-11-01       Impact factor: 25.606

6.  NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.

Authors:  Jun Cui; Liang Zhu; Xiaojun Xia; Helen Y Wang; Xavier Legras; Jun Hong; Jiabing Ji; Pingping Shen; Shu Zheng; Zhijian J Chen; Rong-Fu Wang
Journal:  Cell       Date:  2010-04-30       Impact factor: 41.582

7.  RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate.

Authors:  Andrea Ablasser; Franz Bauernfeind; Gunther Hartmann; Eicke Latz; Katherine A Fitzgerald; Veit Hornung
Journal:  Nat Immunol       Date:  2009-07-16       Impact factor: 25.606

8.  The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria.

Authors:  Teresa L M Thurston; Grigory Ryzhakov; Stuart Bloor; Natalia von Muhlinen; Felix Randow
Journal:  Nat Immunol       Date:  2009-10-11       Impact factor: 25.606

9.  Identification, analysis, and prediction of protein ubiquitination sites.

Authors:  Predrag Radivojac; Vladimir Vacic; Chad Haynes; Ross R Cocklin; Amrita Mohan; Joshua W Heyen; Mark G Goebl; Lilia M Iakoucheva
Journal:  Proteins       Date:  2010-02-01

10.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.

Authors:  David A Barbie; Pablo Tamayo; Jesse S Boehm; So Young Kim; Susan E Moody; Ian F Dunn; Anna C Schinzel; Peter Sandy; Etienne Meylan; Claudia Scholl; Stefan Fröhling; Edmond M Chan; Martin L Sos; Kathrin Michel; Craig Mermel; Serena J Silver; Barbara A Weir; Jan H Reiling; Qing Sheng; Piyush B Gupta; Raymond C Wadlow; Hanh Le; Sebastian Hoersch; Ben S Wittner; Sridhar Ramaswamy; David M Livingston; David M Sabatini; Matthew Meyerson; Roman K Thomas; Eric S Lander; Jill P Mesirov; David E Root; D Gary Gilliland; Tyler Jacks; William C Hahn
Journal:  Nature       Date:  2009-10-21       Impact factor: 49.962

View more
  124 in total

Review 1.  Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease.

Authors:  Xuetao Cao
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

Review 2.  A proteomics perspective on viral DNA sensors in host defense and viral immune evasion mechanisms.

Authors:  Marni S Crow; Aaron Javitt; Ileana M Cristea
Journal:  J Mol Biol       Date:  2015-02-26       Impact factor: 5.469

3.  Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus.

Authors:  Lian-Ju Li; Zhi-Wei Zhu; Wei Zhao; Sha-Sha Tao; Bao-Zhu Li; Shu-Zhen Xu; Jie-Bing Wang; Ming-Yue Zhang; Jun Wu; Rui-Xue Leng; Yin-Guang Fan; Hai-Feng Pan; Dong-Qing Ye
Journal:  Immunology       Date:  2018-05-23       Impact factor: 7.397

4.  TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1.

Authors:  Yunfei Qin; Qingxiang Liu; Shuo Tian; Weihong Xie; Jun Cui; Rong-Fu Wang
Journal:  Cell Res       Date:  2016-02-26       Impact factor: 25.617

5.  SOCS3 Drives Proteasomal Degradation of TBK1 and Negatively Regulates Antiviral Innate Immunity.

Authors:  Dong Liu; Chunjie Sheng; Shijuan Gao; Chen Yao; Jiandong Li; Wei Jiang; Huiming Chen; Jiaoxiang Wu; Changchuan Pan; Shuai Chen; Wenlin Huang
Journal:  Mol Cell Biol       Date:  2015-05-04       Impact factor: 4.272

Review 6.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

7.  The Scaffolding Protein IQGAP1 Interacts with NLRC3 and Inhibits Type I IFN Production.

Authors:  Aaron M Tocker; Emily Durocher; Kimberly D Jacob; Kate E Trieschman; Suzanna M Talento; Alma A Rechnitzer; David M Roberts; Beckley K Davis
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

8.  Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon.

Authors:  Qinjie Zhou; Alfonso Lavorgna; Melissa Bowman; John Hiscott; Edward W Harhaj
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

9.  Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination.

Authors:  Wei Zhao; Qingtian Li; Stephen Ayers; Yifeng Gu; Zhong Shi; Qingyuan Zhu; Yidong Chen; Helen Y Wang; Rong-Fu Wang
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

10.  The NLRP4-DTX4 axis: a key suppressor of TBK1 and innate antiviral signaling.

Authors:  Soratree Charoenthongtrakul; Linlin Gao; Edward W Harhaj
Journal:  Cell Mol Immunol       Date:  2012-10-15       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.